A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a phase 1 study in which healthy adult volunteers will receive BRII-196/BRII-198 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.
Epistemonikos ID: b75b9dc6ad02c34d35d1b8d78b4648a48caa4f74
First added on: Jan 01, 2021